Not for human or veterinary administration. Listed strength is a supplied specification; see the matching batch report for measured results.
Batch documentation
1 report is available for this strength. Match the reported sample and available batch identifiers; contact support if the link to your vial is unclear.
KPV is a three-amino-acid sequence from the end of alpha-melanocyte-stimulating hormone. Researchers investigate its interaction with peptide transport pathways and inflammatory responses in intestinal and immune cells.
What is it studied for?
Inflammatory signalling in cell models
PepT1-mediated peptide transport
Experimental intestinal inflammation
EXPLORE THE EVIDENCE
Studies & research references
Each source identifies what was studied and the limits of its findings. Published research is separate from this product’s batch COA.
Experiments investigated PepT1-mediated KPV transport, inflammatory signalling and chemically induced colitis in mice. These findings do not establish treatment of inflammatory bowel disease in people.
Cell experiments and a mouse colitis model evaluated KPV in hyaluronic-acid-functionalised nanoparticles and a hydrogel. Results from that delivery system cannot be transferred to an unformulated vial or a blend.
KPV is currently listed in 10 mg. Select a strength above to see its price, product image and current stock. Listed quantities are supplied specifications, not measured batch results.
Is a COA available for KPV?
1 laboratory report is published for this compound. Match the selected strength and available batch identifiers, and open the original document to check the actual test scope.
The references discuss the material and experimental conditions in those studies. They do not verify the identity, purity, quantity or suitability of this catalogue vial. Review the study limitations and the available batch documentation separately.